CEFOACT CV 325* TAB
APPLICATION
Capodoxime Proxetil 50 mg. Disp. Tab. / 100 mg. 1200 mg. Tablets & 50 mg. / 5m1 Dry Syp.
The oral power with parenteral spectrum
Surgical wound infections
Chronic Bronchitis
Sinusitis
Acute otitis media
Pharyngitis
Tonsillitis
The only third generation cephalosporin with
* Extended Spectrum
Active against a wide range of Gram +ve & Gram -ye bacteria
Highly stable in the presence of B-lactamase producing organisms
Similar spectrum of antimicrobial activity as Ceftriaxone
* Achieves effective fluid and tissue levels.
* Power of Injectable
* Shorter course of Treatment Increases patient compliance. Lowers treatment Cost
* Twice daily dosage convenience
* Unmatched safety and tolerability
Also available
CEFOACT-CV 325 Cefpodoxime 200 mg. + Clavulanic Acid 125 mg. Tablets A Versatile Active and Safe Combination for Complete Protection